C8B Antikörper (AA 55-350)
-
- Target Alle C8B Antikörper anzeigen
- C8B (Complement Component 8, beta Polypeptide (C8B))
-
Bindungsspezifität
- AA 55-350
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser C8B Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Complement component C8 beta chain protein (55-350AA)
- Isotyp
- IgG
- Top Product
- Discover our top product C8B Primärantikörper
-
anti-Complement Component 8, beta Polypeptide (C8B) (AA 161-503) antibody
C8B Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 55-350) antibodyC8B Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 393-422), (C-Term) antibodyC8B Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB30678 unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 321-370) antibodyC8B Reaktivität: Human, Hund, Rind (Kuh), Pferd, Affe, Fledermaus WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 451-500) antibodyC8B Reaktivität: Human, Maus, Ratte, Hund, Meerschweinchen, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 161-503) antibodyC8B Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (Middle Region) antibodyC8B Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (C-Term) antibodyC8B Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Schwein WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component 8, beta Polypeptide (C8B) (AA 393-422) antibodyC8B Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- C8B (Complement Component 8, beta Polypeptide (C8B))
- Andere Bezeichnung
- C8B (C8B Produkte)
- Hintergrund
-
Background: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells.
Aliases: C8b antibody, CO8B_HUMAN antibody, Complement component 8 beta polypeptide antibody, Complement component 8 subunit beta antibody, Complement component C8 beta chain antibody
- UniProt
- P07358
- Pathways
- Komplementsystem
-
